Otsuka Pharmaceutical Co., Ltd. And Lundbeck Inc. To Present New Data On Brexpiprazole In Major Depressive Disorder (MDD) At European Psychiatry Association 2014 Congress
Published: Jan 24, 2014
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced that the first phase III data on their investigational compound brexpiprazole will be presented in an upcoming poster session at the 22nd European Psychiatry Association Congress (EPA) on March 2, 2014.
Help employers find you! Check out all the jobs and post your resume.